Evidence map›Paper›PMID 29692871›Full record

ArticleDisease markers2018

Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-

P Bayrak Degirmenci, S Aksun, Z Altin, F Bilgir, I B Arslan, H Colak, B Ural, D Solakoglu Kahraman, G Diniz, B Ozdemir and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Clinical Efficacy of TM02Current issues in molecular biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pharmaceutics · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

P Bayrak DegirmenciAllergy Immunology Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.ORCID 0000-0003-0039-302X
S AksunDepartment of Biochemistry, Katip Celebi University, Izmir, Turkey.
Z AltinInternal Medicine Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.
F BilgirAllergy Immunology Department, Ataturk Training and Research Hospital, Katip Celebi University, Izmir, Turkey.
I B ArslanEar, Nose, and Throat Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.ORCID 0000-0001-6987-3887
H ColakNephrology Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.
B UralGeneral Surgery Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.
D Solakoglu KahramanPathology Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.
G DinizPathology Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey.ORCID 0000-0003-1512-7584
B OzdemirAllergy Immunology Department, Manisa State Hospital, Manisa, Turkey.
C KırmazDepartment of Internal Medicine, Division of Allergy Immunology, Manisa Celal Bayar University, Manisa, Turkey.
Izmir University · TRIzmir Kâtip Çelebi University · TRManisa Celal Bayar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed in our study to research the role of new cytokines such as IL-35, IL-22, and IL-17 that may form a target for novel treatment approaches.

methodsIL-10, IL-17, TGF-

resultsIn total, 65 AR patients (patient group), having 31 PAR and 34 SAR patients, and 31 healthy individuals (control group) participated in the study. Cytokine levels between the patient group and the control group were compared; IL-17 (

conclusionsAccompanied by the literature information, these results made us think that T cell subgroups and cytokines have an important role in AR immunopathogenesis. It is thought that future studies to be conducted relating to this subject will form new targets in treatment.

Indexed as

AdultBiomarkersFemaleHumansInterferon-gammaInterleukinsMaleRhinitis, AllergicTumor Necrosis Factor-alphaBiomarkersInterferon-gammaInterleukinsTumor Necrosis Factor-alpha

Identifiers

PMID29692871
PMCPMC5859791
OpenAlexW2792795859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.